1. Home
  2. MRNA
  3. MRNA News

Latest Moderna Inc. (MRNA) News on December 18, 2024

MRNA

Investing.com

6 hours ago

Argus downgrades Moderna to hold on weak near-term outlook

MRNA

MT Newswires

9 hours ago

Argus Downgrades Moderna to Hold From Buy

Hedge Funds Think That Moderna, Inc. (MRNA) Will Bounce Back Soon
MRNA

Insider Monkey

10 hours ago

Hedge Funds Think That Moderna, Inc. (MRNA) Will Bounce Back Soon

MRNA

Argus Research

11 hours ago

Analyst Report: Moderna Inc

MRNA

Argus Research

11 hours ago

Market Digest: RY, AEE, ETR, EXC, K, RCL, BYON, MRNA

3 No-Brainer Biotech Stocks to Buy With $200 Right Now
MRNA

Motley Fool

12 hours ago

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Moderna pauses its RSV vaccine trial for children after 5 infants are hospitalized in latest challenge of preventing disease
MRNA

Fortune

2 days ago

Moderna pauses its RSV vaccine trial for children after 5 infants are hospitalized in latest challenge of preventing disease

Palantir Falls Despite Nasdaq 100 News, MicroStrategy Rises; Super Micro Gets The Axe
MRNA

Investor's Business Daily

2 days ago

Palantir Falls Despite Nasdaq 100 News, MicroStrategy Rises; Super Micro Gets The Axe

What's Going On With Moderna Stock On Monday?
MRNA

Benzinga

2 days ago

What's Going On With Moderna Stock On Monday?

Some of This Year's Big Losers Look Good to Me
MRNA

GuruFocus.com

2 days ago

Some of This Year's Big Losers Look Good to Me

Palantir, MicroStrategy, and Axon Are Joining the Nasdaq 100. Only 1 of the Stocks Is Rising.
MRNA

Barrons.com

2 days ago

Palantir, MicroStrategy, and Axon Are Joining the Nasdaq 100. Only 1 of the Stocks Is Rising.

MicroStrategy, Palantir, Axon to join the Nasdaq 100 next week
MRNA

Yahoo Finance Video

2 days ago

MicroStrategy, Palantir, Axon to join the Nasdaq 100 next week

Palantir, MicroStrategy Getting Added to Nasdaq 100. Here’s How the Stocks Are Trading.
MRNA

Barrons.com

2 days ago

Palantir, MicroStrategy Getting Added to Nasdaq 100. Here’s How the Stocks Are Trading.

Palantir, MicroStrategy, Axon Join Nasdaq 100; Moderna, Super Micro Get The Axe
MRNA

Investor's Business Daily

5 days ago

Palantir, MicroStrategy, Axon Join Nasdaq 100; Moderna, Super Micro Get The Axe

Annual Changes to the Nasdaq-100 Index®
MRNA

GlobeNewswire

5 days ago

Annual Changes to the Nasdaq-100 Index®

Alphabet and 9 More Stocks to Buy for 2025
MRNA

Barrons.com

5 days ago

Alphabet and 9 More Stocks to Buy for 2025

Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?
MRNA

Investor's Business Daily

5 days ago

Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?

Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?
MRNA

Investor's Business Daily

5 days ago

Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?

FDA panel seeks more data on RSV vaccine safety in infants
MRNA

BioPharma Dive

5 days ago

FDA panel seeks more data on RSV vaccine safety in infants

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
MRNA

CNN Business

6 days ago

The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies
MRNA

MarketWatch

6 days ago

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies

These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over
MRNA

Motley Fool

6 days ago

These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates
MRNA

Zacks

7 days ago

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates

Moderna reinstated with an Underperform at BofA
MRNA

TipRanks

7 days ago

Moderna reinstated with an Underperform at BofA

BofA downgrades Moderna, says it's 'tough time' to be vaccine maker
MRNA

Yahoo Finance Video

8 days ago

BofA downgrades Moderna, says it's 'tough time' to be vaccine maker

S&P 500 Gains and Losses Today: Walgreens Pops Following Reports of Buyout Talks
MRNA

Investopedia

8 days ago

S&P 500 Gains and Losses Today: Walgreens Pops Following Reports of Buyout Talks

Moderna Stock Is Struggling. BofA Doesn’t See Things Getting Better.
MRNA

Barrons.com

8 days ago

Moderna Stock Is Struggling. BofA Doesn’t See Things Getting Better.

Here's Why We're Watching Moderna's (NASDAQ:MRNA) Cash Burn Situation
MRNA

Simply Wall St.

12 days ago

Here's Why We're Watching Moderna's (NASDAQ:MRNA) Cash Burn Situation

Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup
MRNA

Quartz

13 days ago

Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup

Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?
MRNA

Motley Fool

13 days ago

Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2024?

Moderna opens Southern Hemisphere’s only mRNA manufacturing facility in Victoria
MRNA

Investment Monitor

14 days ago

Moderna opens Southern Hemisphere’s only mRNA manufacturing facility in Victoria

Moderna CEO says he'll work with Trump using 'facts and data'
MRNA

Quartz

14 days ago

Moderna CEO says he'll work with Trump using 'facts and data'

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds
MRNA

South China Morning Post

15 days ago

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

MRNA

Investing.com

15 days ago

Moderna shares could slump over 30% on negative CMV reading: Leerink

Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?
MRNA

Insider Monkey

16 days ago

Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?

MRNA

Morningstar Research

16 days ago

Analyst Report: Moderna, Inc.

Moderna, Inc. (MRNA): A Bull Case Theory
MRNA

Insider Monkey

18 days ago

Moderna, Inc. (MRNA): A Bull Case Theory

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?
MRNA

Insider Monkey

21 days ago

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?

Moderna price target lowered to $45 from $59 at JPMorgan
MRNA

TipRanks

21 days ago

Moderna price target lowered to $45 from $59 at JPMorgan

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
MRNA

Motley Fool

22 days ago

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over

Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now
MRNA

Insider Monkey

22 days ago

Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now

Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships
MRNA

GuruFocus.com

22 days ago

Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships

MRNA

MT Newswires

23 days ago

JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating

Top S&P 500 performers year-to-date: Vistra, Nvidia, Palantir
MRNA

Yahoo Finance Video

23 days ago

Top S&P 500 performers year-to-date: Vistra, Nvidia, Palantir

MRNA

MT Newswires

23 days ago

RBC Cuts Price Target on Moderna to $50 From $62, Maintains Sector Perform Rating

Moderna to Present at Upcoming Conferences in December 2024
MRNA

ACCESSWIRE

23 days ago

Moderna to Present at Upcoming Conferences in December 2024

Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge Funds
MRNA

Insider Monkey

25 days ago

Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge Funds

MRNA

Investing.com

a month ago

Jefferies says market nears short term “peak RFK negativity", Vaccine makers up

Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
MRNA

Insider Monkey

a month ago

Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock

Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
MRNA

Investopedia

a month ago

Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?
MRNA

Insider Monkey

a month ago

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?

Matt Gaetz Withdraws. Why That Might Be Bad News for RFK.
MRNA

Barrons.com

a month ago

Matt Gaetz Withdraws. Why That Might Be Bad News for RFK.

Is Investing in Moderna Stock (NASDAQ:MRNA) Simply Dead Money?
MRNA

TipRanks

a month ago

Is Investing in Moderna Stock (NASDAQ:MRNA) Simply Dead Money?

Is Moderna Stock A Sell With Deep Losses Projected For The Fourth Quarter?
MRNA

Investor's Business Daily

a month ago

Is Moderna Stock A Sell With Deep Losses Projected For The Fourth Quarter?

MRNA

MT Newswires

a month ago

Baptista Upgrades Moderna to Buy, Price Target at $48

Moderna initiated with a Hold at Berenberg
MRNA

TipRanks

a month ago

Moderna initiated with a Hold at Berenberg

HSBC upgrades Moderna to Buy on pipeline potential
MRNA

TipRanks

a month ago

HSBC upgrades Moderna to Buy on pipeline potential

MRNA

MT Newswires

a month ago

Berenberg Initiates Moderna at Hold, With $42 Price Target

Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
MRNA

Benzinga

a month ago

Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination

MRNA

Investing.com

a month ago

Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential

MRNA

MT Newswires

a month ago

Piper Sandler Cuts Moderna Price Target to $69 From $115, Maintains Overweight Rating

MRNA

MT Newswires

a month ago

Leerink Partners Adjusts Moderna Price Target to $31 From $38, Maintains Underperform Rating

MRNA

MT Newswires

a month ago

HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82

MRNA

Morningstar Research

a month ago

Analyst Report: Moderna, Inc.

Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
MRNA

Investor's Business Daily

a month ago

Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS

How analysts are reacting to RFK Jr. as Trump's HHS pick
MRNA

Yahoo Finance Video

a month ago

How analysts are reacting to RFK Jr. as Trump's HHS pick

MRNA

MT Newswires

a month ago

Update: Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary

Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now
MRNA

Insider Monkey

a month ago

Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
MRNA

Yahoo Finance Video

a month ago

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
MRNA

Yahoo Finance

a month ago

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
MRNA

The Wall Street Journal

a month ago

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary
MRNA

FastCompany

a month ago

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
MRNA

Investor's Business Daily

a month ago

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS

Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary
MRNA

Quartz

a month ago

Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary

Trump’s RFK Jr. Pick Weighs on Vaccine Makers
MRNA

The Wall Street Journal

a month ago

Trump’s RFK Jr. Pick Weighs on Vaccine Makers

RFK Jr. News Hits Global Pharma Stocks
MRNA

The Wall Street Journal

a month ago

RFK Jr. News Hits Global Pharma Stocks

MRNA

MT Newswires

a month ago

Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary

Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.
MRNA

Barrons.com

a month ago

Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
MRNA

Yahoo Finance

a month ago

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

The Oncology Bet Is Already Paying Off For Pfizer
MRNA

Benzinga

a month ago

The Oncology Bet Is Already Paying Off For Pfizer

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
MRNA

Yahoo Finance

a month ago

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
MRNA

Pharmaceutical Technology

a month ago

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
MRNA

ACCESSWIRE

a month ago

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year

MRNA

MT Newswires

a month ago

Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating

Moderna’s mRESVIA vaccine gains Health Canada approval
MRNA

Pharmaceutical Technology

a month ago

Moderna’s mRESVIA vaccine gains Health Canada approval

Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
MRNA

Simply Wall St.

a month ago

Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
MRNA

Benzinga

a month ago

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn

MRNA

MT Newswires

a month ago

Jefferies Adjusts Moderna Price Target to $50 From $55

MRNA

MT Newswires

a month ago

Goldman Sachs Adjusts Moderna Price Target to $112 From $130

MRNA

MT Newswires

a month ago

Leerink Partners Adjusts Moderna Price Target to $38 From $46

MRNA

MT Newswires

a month ago

Barclays Adjusts Moderna Price Target to $111 From $125

MRNA

MT Newswires

a month ago

BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating

2 Biotech Stocks You Can Buy Hand Over Fist This Month
MRNA

Motley Fool

a month ago

2 Biotech Stocks You Can Buy Hand Over Fist This Month

Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
MRNA

Zacks

a month ago

Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

MRNA

MT Newswires

a month ago

Moderna Says RSV Vaccine Approved by Health Canada for Older Adults

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
MRNA

PR Newswire

a month ago

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
MRNA

ACCESSWIRE

a month ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

Moderna Third Quarter 2024 Earnings: Beats Expectations
MRNA

Simply Wall St.

a month ago

Moderna Third Quarter 2024 Earnings: Beats Expectations

Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...
MRNA

GuruFocus.com

a month ago

Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'
MRNA

Investor's Business Daily

a month ago

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'

Share on Social Networks: